Lung cancer (Amsterdam, Netherlands)

Keyphrases

Publications

volume 196, 2024

Stephanie Peeters, Kelvin Lau, Konstantinos Stefanidis, Kazuhiro Yasufuku, Tsukasa Ishiwata, Christian Rolfo, Didier Schneiter, Georgia Hardavella, Matthias Guckenberger, Olivia Lauk
New diagnostic and nonsurgical local treatment modalities for early stage lung cancer. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Meng-Zhu Zheng, Zhan-Qun Yang, Sun-Li Cai, Li-Ting Zheng, Yuan Xue, Long Chen, Jian Lin
Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Dehua Liao, Minghui Long, Jiwen Zhang, Xingyu Wei, Fei Li, Ting Yan, Desong Yang
Efficacy and safety of pralsetinib in patients with RET fusion positive non-small cell lung cancer: An observational real world study. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Marion Ferreira, Aurélie Swalduz, Laurent Greillier, Pauline du Rusquec, Hubert Curcio, Judith Raimbourg, Anne-Claire Toffart, Valérie Gounant, Sebastien Couraud, Gonzague De Chabot, Sylvie Friard, José Hureaux, Gaëlle Jeannin, Luc Odier, Charles Ricordel, Marie Wislez, Clotilde Descarpentries, Guillaume Herbreteau, Pascale Missy, Franck Morin, Virginie Westeel, Alexis B Cortot
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Guanyu Yang, Qinjun Chu
Comment on: Effects of pregabalin combined with tramadol/paracetamol on acute pain in patients with CT-guided puncture localization of pulmonary nodules. Lung cancer (Amsterdam, Netherlands) 196 (2024)
David M Waterhouse, Sacha Rothschild, Christophe Dooms, Bertrand Mennecier, Farastuk Bozorgmehr, Margarita Majem, Michel H van den Heuvel, Helena Linardou, Byoung Chul Cho, Rachel Roberts-Thomson, Kentaro Tanaka, Normand Blais, Gustavo Schvartsman, Karin Holmskov Hansen, Izabela Chmielewska, Martin D Forster, Christina Giannopoulou, Björn Stollenwerk, Cynthia C Obiozor, Yang Wang, Silvia Novello
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Carolyn J Presley, Joy Tang, Jason Benedict, Madison Grogan, Sarah Reisinger, Sarah Janse, Melisa L Wong, Nicole A Arrato, Ashley Davenport, Peter G Shields, Barbara L Andersen
Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V Liu
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Chang Zhu
What's behind thoracic surgery explosion in young patients under the age of 40 in Wuhan after COVID-19 outbreak? Lung cancer (Amsterdam, Netherlands) 196 (2024)
Martin Reck, Rafal Dziadziuszko, Shunichi Sugawara, Steven Kao, Maximilian Hochmair, Florian Huemer, Gilberto de Castro, Libor Havel, Reyes Bernabé Caro, György Losonczy, Jong-Seok Lee, Dariusz M Kowalski, Zoran Andric, Raffaele Califano, Andrea Veatch, Gregory Gerstner, Marta Batus, Stefanie Morris, Monika Kaul, Vaikunth Cuchelkar, Huafei Li, Bradford J Danner, Barzin Y Nabet, Stephen V Liu
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Yukiko Shimoda Igawa, Tatsuya Yoshida, Reiko Makihara, Masahiro Torasawa, Akiko Tateishi, Yuji Matsumoto, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification. Lung cancer (Amsterdam, Netherlands) 196 (2024)
Ryota Shibaki, Daichi Fujimoto, Eisaku Miyauchi, Yoko Tsukita, Ichiro Nakachi, Daisuke Arai, Yoshihiko Sakata, Naoki Shingu, Toshio Shimokawa, Takashi Kijima, Motohiro Tamiya, Sachiko Kawana, Satoshi Hara, Go Saito, Yuki Sato, Toshihide Yokoyama, Shinya Sakata, Yoshihiko Taniguchi, Akito Hata, Hirotaka Matsumoto, Teppei Yamaguchi, Nobuyuki Yamamoto
Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial. Lung cancer (Amsterdam, Netherlands) 196 (2024)
F O Mildner, M M Sykora, H Hackl, A Amann, B Zelger, S Sprung, M L Buch, F Nocera, P Moser, H Maier, F Augustin, C Manzl, F Kocher, A Pircher, J Lindenmann, I Mykoliuk, S Raftopoulou, J Kargl, D Wolf, S Sopper, G Gamerith
Soluble PD-L1 shows no association to relapse and overall survival in early stage non-small cell lung cancer (NSCLC). Lung cancer (Amsterdam, Netherlands) 196 (2024)
Geeske F Grit, Esmée van Geffen, Ruben Malmberg, Roelof van Leeuwen, Stefan Böhringer, Hans Jm Smit, Pepijn Brocken, Job Fh Eijsink, Esther Dronkers, Pim Gal, Eva Jaarsma, Regine Jhm van Drie-Pierik, Anne Mp Eldering-Heldens, A N Machteld Wymenga, Peter Gm Mol, Juliëtte Zwaveling, Doranne Hilarius
Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective. Lung cancer (Amsterdam, Netherlands) 196 (2024)

volume 195, 2024

Ke-Jun Liu, Hong-Rui Li, Quan-Quan Tan, Tao Jiang, Kai-Cheng Peng, Hua-Jun Chen, Qing Zhou, Xu-Chao Zhang, Zheng Zheng, Shi-Yuan Chen, Xue Zheng, Hong-Bo Zheng, Bei-Bei Mao, Long-Long Gong, Xian-Wen Chen, Wendy Wu, Yi-Long Wu, Jun Jia, Jin-Ji Yang
Tumor immune microenvironment of NSCLC with EGFR exon 20 insertions may predict efficacy of first-line ICI-combined regimen. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, David J Kwiatkowski, Shiven Patel, Lyudmila A Bazhenova, Patrick Forde, Yanyan Lou, Paul Dizona, Liza C Villaruz, Susanne M Arnold, Maya Khalil, Hedy L Kindler, Marianna Koczywas, Jose Pacheco, Christian Rolfo, Bing Xia, Elizabeth Mikula, Li Chen, Kashish Patel, Katherine E R Smith, Liang Cao, Geoffrey Shapiro, Brian A Costello, Alex Adjei, Elad Sharon, Jeffrey A Moscow, William Zamboni, Raffit Hassan
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma. Lung cancer (Amsterdam, Netherlands) 195 (2024)
S Klebe, Vivek Rathi, P A Russell
Lung cancer caused by asbestos: What a reporting pathologist needs to know. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Shun Lu, Yiping Zhang, Guojun Zhang, Jianying Zhou, Shundong Cang, Ying Cheng, Gang Wu, Peiguo Cao, Dongqing Lv, Hong Jian, Xiangming Jin, Chengshui Chen, Panwen Tian, Kai Wang, Guanming Jiang, Gongyan Chen, Qun Chen, Hui Zhao, Cuimin Ding, Renhua Guo, Guoping Sun, Bin Wang, Liyan Jiang, Zhe Liu, Jian Fang, Junquan Yang, Wu Zhuang, Yunpeng Liu, Jian Zhang, Yueyin Pan, Jun Chen, Qitao Yu, Min Zhao, Jiuwei Cui, Dianming Li, Tienan Yi, Zhuang Yu, Yan Yang, Yan Zhang, Xiuyi Zhi, Yunchao Huang, Rong Wu, Liangan Chen, Aimin Zang, Lejie Cao, Qingshan Li, Xiaoling Li, Yong Song, Donglin Wang, Shucai Zhang, Lieming Ding, Ling Zhang, Dong Ji, Zhilin Shen
Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Monica Casiraghi, Andrea Cara, Antonio Mazzella, Lara Girelli, Giorgio Lo Iacono, Clarissa Uslenghi, Giovanni Caffarena, Riccardo Orlandi, Luca Bertolaccini, Patrick Maisonneuve, Lorenzo Spaggiari
1000 Robotic-assisted lobectomies for primary lung cancer: 16 years single center experience. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, Stephen V Liu, Barbara Melosky, Devin Abrahami, Benjamin Li, Despina Thomaidou, Kirsten Duncan, Stan Krulewicz, Martin Rupp, Jessica J Lin
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Julia Naso, Aakash Desai, Caleb J Smith, Yash P Ashara, Stephen Yip, Ying-Chun Lo
Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Panagiotis Tasoudis, Georgios Loufopoulos, Vasiliki Manaki, Mitchell Doerr, Chris B Agala, Jason M Long, Benjamin E Haithcock
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Jyoti Malhotra, Alberto Chiappori, Naomi Fujioka, Nasser H Hanna, Lawrence E Feldman, Malini Patel, Dirk Moore, Chunxia Chen, Salma K Jabbour
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Yiqun Wei, Runmiao Wu, Shuanying Yang, Yanfei Cao, Jing Li, Huihui Ma, Junfang Wu, Jinjin Duan, Shumei Yang
MiR-137 mediated high expression of TIGD1 promotes migration, invasion, and suppresses apoptosis of lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Yao Ding, Shun Lei, Ling Wang, Long Tang, Yue Zhang, Yiran Liao, Xia Deng, Yan Li, Yi Gong, Yongsheng Li
Age-related efficacy of immunotherapies in advanced non-small cell lung cancer: a comprehensive meta-analysis. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Adam Barsouk, Omar Elghawy, Alec Heidlauf, Connie Yu, Lucy Wang, David Yang, Martin Kurian, Keshav Goel, Lynn Rushkin, Anna Anran Huang, Lauren Reed-Guy, Benjamin Bleiberg, Lova Sun, Aditi Singh, Roger B Cohen, Charu Aggarwal, Melina Marmarelis, Corey Langer
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Virginia Calvo, Emetis Niazmand, Enric Carcereny, Delvys Rodriguez-Abreu, Manuel Cobo, Rafael López-Castro, María Guirado, Carlos Camps, Ana Laura Ortega, Reyes Bernabé, Bartomeu Massutí, Rosario Garcia-Campelo, Edel Del Barco, José Luis González-Larriba, Joaquim Bosch-Barrera, Marta Martínez, María Torrente, María-Esther Vidal, Mariano Provencio
Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Lisha Ying, Tingting Lu, Yiping Tian, Hui Guo, Conghui Wu, Chen Xu, Jiaoyue Jin, Rui Zhu, Pan Liu, Ying Yang, Chaodan Yang, Wenyu Ding, Chenyang Xu, Minran Huang, Zhengxiao Ma, Yuting Zhang, Yue Zhuo, Ruiyang Zou, Dan Su
A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Akihiro Tamiya, Mitsuo Osuga, Daijiro Harada, Shun-Ichi Isa, Yoshihiko Taniguchi, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando, Yasuhiro Koh
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Ying Li, Fangfang Xie, Qiang Zheng, Yujun Zhang, Wei Li, Minjie Xu, Qiye He, Yuan Li, Jiayuan Sun
Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Najmeh Alirezaie, Anne-Laure Chong, Felix K F Kommoss, Nelly Sabbaghian, Jose Camacho Valenzuela, Dylan Pelletier, Javad Nadaf, Shailesh B Kolekar, Pradeesh Sivapalan, Mark G Evans, Paul S Thorner, Pierre-Olivier Fiset, Andreas von Deimling, William D Foulkes
Exomic and epigenomic analysis of pulmonary blastoma. Lung cancer (Amsterdam, Netherlands) 195 (2024)
Nelly Otte, Ellen Fraune, Yildiz Cetiner, Michael K Felten, Timm Dirrichs, Julia Krabbe, Thomas Kraus
Asbestos Surveillance Program Aachen (ASPA): Cancer mortality among asbestos exposed power industry workers. Lung cancer (Amsterdam, Netherlands) 195 (2024)

volume 194, 2024

Yu Jung Kim, Soyeon Kim, Tae Min Kim, Koung Jin Suh, Miso Kim, Se Hyun Kim, Bhumsuk Keam, Dong-Wan Kim, Jong Seok Lee, Dae Seog Heo
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19). Lung cancer (Amsterdam, Netherlands) 194 (2024)
Mathilde Jacob, Pierre Fournel, Claire Tissot, Jacques Cadranel, Olivier Bylicki, Isabelle Monnet, Grégoire Justeau, Charles Ricordel, Pascal Thomas, Lionel Falchero, Chrystel Locher, Marie Wislez, Alain Vergnenegre, Samir Abdiche, Floran Guisier, Acya Bizieux, Regine Lamy, Geraldine François, Gonzagues De Chabot, Thomas Pierret, Marie Sabatini, Marion Abeillera, Sabine Vieillot, Stephanie Martinez, Hugues Morel, Hélène Doubre, Anne Madroszyk, Margaux Geier, Jean LucLabourey, Christos Chouaïd, Laurent Greillier
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study). Lung cancer (Amsterdam, Netherlands) 194 (2024)
Rongzhen Li, Yan Xu, Jing Zhao, Li Zhang, Wei Zhong, Xiaoxing Gao, Xiaoyan Liu, Minjiang Chen, Mengzhao Wang
Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Benedikt Niedermaier, Yao Kou, Elizabeth Tong, Monika Eichinger, Laura V Klotz, Martin E Eichhorn, Thomas Muley, Felix Herth, Hans-Ulrich Kauczor, Claus Peter Heußel, Hauke Winter
CT-guided needle biopsy is not associated with increased ipsilateral pleural metastasis. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Lorenzo Belluomini, Ursula Cesta Incani, Annafrancesca Smimmo, Alice Avancini, Marco Sposito, Jessica Insolda, Ilaria Mariangela Scaglione, Federica Gattazzo, Simone Caligola, Annalisa Adamo, Fabiana Conciatori, Chiara Bazzichetto, Stefano Ugel, Diana Giannarelli, Sara Pilotto, Michele Milella
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Nico van Zandwijk, Arthur L Frank, Glen Reid, Oluf Dimitri Røe, Christopher I Amos
Asbestos-Related lung Cancer: An underappreciated oncological issue. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Elvire Pons-Tostivint, Remy Ezzedine, Thomas Goronflot, Perrine Crequit, Thierry Chatellier, Judith Raimbourg, Jaafar Bennouna, Etienne Giroux Leprieur, Marie Porte
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Chinatsu Yoshizaki, Yuki Yoshida, Shiho Nohmi, Yoshihiro Go, Rui Kusakado, Saori Kawamura, Daisuke Inoue, Nobuyuki Kabasawa, Fumihiro Yamaguchi
EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Ernst-Jan M Speel, Urania Dafni, Erik Thunnissen, Jan Hendrik Rüschoff, Cathal O'Brien, Jacek Kowalski, Keith M Kerr, Lukas Bubendorf, Irene Sansano, Leena Joseph, Mark Kriegsmann, Atilio Navarro, Kim Monkhorst, Line Bille Madsen, Javier Hernandez Losa, Wojciech Biernat, Albrecht Stenzinger, Andrea Rüland, Lisa M Hillen, Nesa Marti, Miguel A Molina-Vila, Tereza Dellaporta, Roswitha Kammler, Solange Peters, Rolf A Stahel, Stephen P Finn, Teodora Radonic, null null
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Olivier Bylicki, Florian Guisier, Arnaud Scherpereel, Catherine Daniel, Aurélie Swalduz, Emmanuel Grolleau, Marie Bernardi, Stephane Hominal, Jean Briac Prevost, Guillaume Pamart, Marie Héléne Marques, Nicolas Cloarec, Simon Deshayes, Judith Raimbourg, Rémi Veillon, Youssef Oulkhouir, Clarisse Audigier Valette, Fabien Subtil, Christos Chouaïd, Laurent Greillier, null null
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Rongzhen Li, Yan Xu, Jing Zhao, Li Zhang, Wei Zhong, Xiaoxing Gao, Xiaoyan Liu, Minjiang Chen, Mengzhao Wang
Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Yingqi Xu, Yidan Zhang, Huiping Qiang, Hua Zhong, Jianlin Xu, Runbo Zhong
Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Motohiro Izumi, Daniel B Costa, Susumu S Kobayashi
Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Elvire Pons-Tostivint, Remy Ezzedine, Thomas Goronflot, Perrine Crequit, Thierry Chatellier, Judith Raimbourg, Jaafar Bennouna, Etienne Giroux Leprieur, Marie Porte
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Ernst-Jan M Speel, Urania Dafni, Erik Thunnissen, Jan Hendrik Rüschoff, Cathal O'Brien, Jacek Kowalski, Keith M Kerr, Lukas Bubendorf, Irene Sansano, Leena Joseph, Mark Kriegsmann, Atilio Navarro, Kim Monkhorst, Line Bille Madsen, Javier Hernandez Losa, Wojciech Biernat, Albrecht Stenzinger, Andrea Rüland, Lisa M Hillen, Nesa Marti, Miguel A Molina-Vila, Tereza Dellaporta, Roswitha Kammler, Solange Peters, Rolf A Stahel, Stephen P Finn, Teodora Radonic, null null
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Hiroyuki Ogawa, Takamasa Koga, Nhu-An Pham, Nicholas Bernards, Alexander Gregor, Yuki Sata, Shinsuke Kitazawa, Yoshihisa Hiraishi, Tsukasa Ishiwata, Masato Aragaki, Fumi Yokote, Andrew Effat, Kate Kazlovich, Quan Li, Katrina Hueniken, Ming Li, Yoshimasa Maniwa, Ming-Sound Tsao, Kazuhiro Yasufuku
Clinical and pathological predictors of engraftment for patient-derived xenografts in lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Chinatsu Yoshizaki, Yuki Yoshida, Shiho Nohmi, Yoshihiro Go, Rui Kusakado, Saori Kawamura, Daisuke Inoue, Nobuyuki Kabasawa, Fumihiro Yamaguchi
EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung cancer (Amsterdam, Netherlands) 194 (2024)
Jii Bum Lee, Yiqing Huang, Yuko Oya, Jorn Nutzinger, Yvonne LE Ang, Kenneth Sooi, Byoung Chul Cho, Ross A Soo
Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities. Lung cancer (Amsterdam, Netherlands) 194 (2024)